TransAction program to improve HIV prevention and care for transgender women in Ho Chi Minh City

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Eighty transgender women will be randomly assigned to receive the full TransAction package (individual risk-reduction sessions, skill-building and open group support sessions, and social events) or to a control condition invited to social events only. Outcomes including movement along the HIV prevention and care continua, sexual risk behavior, substance use, self-efficacy in seeking services, social support, stigma, well-being, and quality of life will be measured at baseline, 3 months, and 6 months. The study will also document implementation outcomes such as fidelity, adaptation, feasibility, acceptability, and sustainability using implementation records, investigator evaluation, and surveys and focus groups with peer facilitators and participants. The trial is led by UCLA in collaboration with local and international partners and is conducted at the University of Medicine and Pharmacy in Ho Chi Minh City.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 16 years of age or older
* being male at birth and currently self-identified as a TW
* currently living in Ho Chi Minh City adjacent areas and having no plans to move out of the areas in the next 6 months - have the cognitive capacity to participate in study activities as judged by the study recruiter.

Exclusion Criteria:

* have been involved in intervention adaptation activities previously with the study team
* inability to give informed consent/assent

Where it's running

• University of Medicine and Pharmacy
  Ho Chi Minh City, Vietnam Recruiting

Study contacts

• Study coordinator: Chunqing Lin, PhD
• Email: lincq@ucla.edu
• Phone: 3107940361

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide

  This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.

  Recruiting Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Paris · NCT07921472

• Multiple interventions to try for HIV remission in people on ART

  This study tests a combination approach, including intensified ART, latency-reversal agents, and autologous dendritic cell therapy, to see if people living with HIV on long-term ART can achieve sustained viral suppression or prolonged remission.

  Recruiting Phase 2 Federal University of São Paulo · São Paulo, São Paulo · NCT07903441

• Stigma Healing Inventory: See if a global program can reduce stigma for kids with cancer and their caregivers

  This study tests a stigma-reduction program for children with cancer and their caregivers to see if it lowers stigma across different cultures.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07882927

• Honest, Open, Proud for justice-involved veterans

  This trial tests a peer-delivered stigma-reduction program for veterans with co-occurring mental health or substance use disorders who are involved with the justice system, to see if different delivery intensities help more veterans engage in care.

  Recruiting VA Office of Research and Development · Bedford, Massachusetts · NCT07742722

• Portable chest X-ray screening to rapidly find TB in migrants

  A community-based TB screening effort using mobile chest X-rays and AI-assisted readings is tested among migrant adults in New York City to see if it helps identify active TB earlier and connect people to care.

  Recruiting Columbia University · New York, New York · NCT07737275

• Care Disengagement Prevention for People Living with HIV in Indonesia

  This intervention tests a stigma-reduction approach to help people living with HIV in Indonesia stay connected with HIV care.

  Recruiting University of California, Los Angeles · Depok, West Java · NCT07706634

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.